We invest in US-incorporated gene tech seed stage startups applying or enabling genomics and synbio to health and happiness (therapeutics, diagnostics, vaccines, cosmetics) and other industries (food/ag, veterinary, materials/chemicals).

In general, we want to connect with startups working with DNA, RNA, proteins, and -omics.